Isoflavone and triterpene glycosides from soybeans

Details Isoflavone and triterpene glycosides from soybeans Isoflavone and triterpene glycosides from soybeans

2006-09-26

2006-09-26

Jiang, Shaojia Anna (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S004100, C536S008000

Reexamination Certificate

active

07112573

ABSTRACT:
The invention provides new isoflavonoid and triterpenoid compounds isolated from a soybean phytochemical concentrate. The new compounds have exhibited cytotoxic activity against selected tumor cell lines. Pharmaceutical compositions comprising the new compounds and methods for use thereof are provided by the invention.

REFERENCES:
patent: 3070623 (1962-12-01), Gottfried et al.
patent: 3070624 (1962-12-01), Baxendale et al.
patent: 4524067 (1985-06-01), Arichi et al.
patent: 5182373 (1993-01-01), Kim et al.
patent: 5952374 (1999-09-01), Clarkson et al.
patent: 6080725 (2000-06-01), Marciani
patent: 753773 (1970-12-01), None
patent: 1346871 (1974-02-01), None
patent: A-4432798 (1969-12-01), None
patent: 2001-72697 (2001-03-01), None
Nikaido et al., “Inhibition of Adenosine 3',5'-Cyclic Monophosphate Phosphodiesterase by Flavonoids. III”, Chemical and Pharmaceutical Bullitin, 37(5), pp. 1392-1395, 1989.
Agrawal, “Carbon-13 NMR of Flavonoids,” Elsevier Science: NY, Studies in Organic Chemistry, 39:192-211, 1989.
Akiyama et al., “Geinstein, a specific inhibitor of tyrosine-specific protein kinases,”J. Biol. Chem.,262(12):5592-5595, 1987.
Arao et al., “Oleanene-type triterpene glycosides from puerariae radix. IV six new saponins from Pueraria lobata,”Chem. Pharm. Bull.,45(2):362-366, 1997.
Choi et al., “Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of P21 in human breast carcinoma cells,”Int. J. Oncol.,13(2):391-396, 1998.
Doll et al, “Clinical trial of a triterpenoid liquorice compound in gastric and duodenal ulcer,”Lancet1:793-796, 1962.
Harborne et al,The Flavonoids; Academic Press: NY, PT2:756-761, 1975.
Hawrylewicz et al, “Soy and experimental cancer: animal studies,”J. Nutr.,125:698S-708S, 1995.
Heinonen et al, “Identification of Isoflavone metabolites dihydrodaidzein, dihydrogenistein, 6'-OH-O-dma, and cis-4-OH-equol in human urine by gas chromatography—mass spectroscopy using authentic reference compounds,”Anal. Biochem.,274:211-219, 1999.
Herman et al., “Soybean phytoestrogen intake and cancer risk,”J. Nutr.,125:757S-770S, 1995.
Hosny and Rosazza, “Novel isoflavone, cinnamic acid, and triterpenoid glycosides in soybean molasses,”J. Nat. Prod.,62:853-858, 1999.
Huang et al., “Antitumor activity of total saponins from Dolichos falcatus Klein,”Zhongueo Yaoii Xuebao,Chemical abstract No. 98:100885, 3:286-288, 1982, Journal in Chinese, English abstract provided.
Inoue et al., “Inhibitory effect of Glycyrrhetinic acid derivatives on lipoxygenase and prostaglandin synthetase,”Chem. Pharm. Bull.34(2):897-901, 1986.
Jing et al, “Differntiation of promyelocytic leukemia cells HL-60 induced by Daidzein in vitro and in vivo,”Anticancer Res.,13:1049-1054, 1993.
Joannou et al, “A urinary profile study of dietary phytoestrogens. The identification and mode metabolism of new isoflavonoids,”J. Steroid Biochem. Molec. Biol,.54(3/4):167-184, 1995.
Kashiwada et al., “Anti-tumor agents. 1361. Cumingianosides A-F, potent antileukemic new triterpene glucosides, and cumindysosides A and B, Trisnor- and Tetranortriterpene glucosides with a 14,18-Cycloapoeuphane-t/ype skeleton from Dysoxylum cumingianum,”J. Org. Chem.,57:6946-6953, 1992.
Kitagawa et al, “Characterization of saponin constituents in soybeans of various origins and quantitative analysis of soyasaponins by gas-liquid chromatography,”Yakugaku Zasshi,104:162-168, 1984, contains an English abstract.
Kitagawa et al, “Saponin and sapogenol. XXXVIII1. Structure of soyasaponin A2, a bisdesmoside of soyasapogenol A, from soybean, the seeds of Glycine max MERILL,”Chem. Pharm. Bull.,33(2):598-608, 1985.
Kong et al., “Triterpeniod glycosides from Decaisnea Fargesii,”Phytochemistry,33(2):427-430, 1993.
Menon et al, “Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells,”Nutr. Cancer,30:74-77, 1998.
Merz-Demlow et al, “Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women,”Am. J. Clin. Nutr.,71:1462-1469, 2000.
Messina et al, “Soy intake and cancer risk: a review of the in vitro and in vivo data,”Nutr. Cancer,21:113-131, 1994.
Messina, “Legumes and soybeans: overview of their nutritional profiles and health effects,”Am. J. Clin. Nutr.,70(Suppl):439S-450S, 1999.
Nagamoto et al., “Antitumor constituents from bulbs of Crocosmia crocosmiiflora,”Planta Medica.,54:305-307, 1988.
Naik et al, “An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer,”Anticancer Res.,14:2617-2619, 1994.
Naim et al, “Antioxidative and antihemolytic activities of soybean isoflavones,”J. Agric. Food Chem.,24(6):1174-1177, 1976.
Nikaido et al., “Inhibition of adenosine 3'5'-cyclic monophosphate phosphodiesterase by flavonoids, III,”Chem. Pharm. Bull.,37(5): 1392-1395, 1989.
Nwokolo and Smartt, “Soybean (Glycine Max (L.) Merr.),” Chapter 8 In:Food and Feed from Legumes and oilseeds:Chapman and Hall: London, 90-102, 1996.
Okura et al, “Effect of genistein on topoisomerase activity and on the growth of [VAL 12] Ha-ras-transformed NIH 3T3 cells,”Biochem. Biophys. Res. Commun.,157:183-189, 1988.
Peterson and Barnes, “Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene,”Biochem. Biophys. Res. Commun.,179:661-667, 1991.
Pisha et al., “Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis,”Nature Medicine,1:1046-1051, 1995.
Pool-Zobel et al, “Isoflavonoids and linans have different potentials to modulate oxidative genetic damage in human colon cells,”Carcinogenesis,21(6):1247-1252, 2000.
Rao and Sung, “Saponins as anticarcinogens,”J. Nutr.,125:717S-724S, 1995.
Rao et al, “Enhancement of experimental colon cancer by genistein,”Cancer Res.,57:3717-3722, 1997.
Setchell, “Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones1,2,”Am. J. Clin. Nutr.,68(Suppl):1333S-1346S, 1998.
Taniyama et al, “Saponin and sapogenol. XLIV.1)Soyasaponin composition in soybeans of various origins and soyasaponin content in various organs of soybean. Structure of Soyasaponin V form soybean hypocotyl,”Yakugaku Zasshi, 108:562-571, 1988, contains an English abstract.
Tezuka et al, “Properties of tofus and soy milks prepared from soybeans having different subunits of glycinin,”J. Agric. Food Chem.,48:1111-1117, 2000.
Tomas-Barbaran et al., “A cytotoxic triterpenoid and flavonoids from crossopteryx febrigua,”Planta Medica.,54:266-267, 1988.
Yanagihara et al, “Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract,”Cancer Res.,53:5815-5821, 1993.
Zhou et al, “Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis,”Cancer Res.,58:5231-5238, 1998.
Zhou et al, “Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice,”J. Nutrit.,129:1628-1635, 1999.

Affiliated with

Also associated with

Rating

Isoflavone and triterpene glycosides from soybeans does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoflavone and triterpene glycosides from soybeans, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoflavone and triterpene glycosides from soybeans will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3577926